{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:19:03Z","timestamp":1781878743718,"version":"3.54.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ratchadapiseksomphot endowment fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vaccines against the sexual stages of the malarial parasite\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      are indispensable for controlling malaria and abrogating the spread of drug-resistant parasites. Pfs25, a surface antigen of the sexual stage of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      , is a leading candidate for transmission-blocking vaccine development. While clinical trials have reported that Pfs25-based vaccines are safe and effective in inducing transmission-blocking antibodies, the extent of the genetic diversity of\n                      <jats:italic>Pfs25<\/jats:italic>\n                      in malaria endemic populations has rarely been studied. Thus, this study aimed to investigate the global diversity of\n                      <jats:italic>Pfs25<\/jats:italic>\n                      in\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A database of 307\n                      <jats:italic>Pfs25<\/jats:italic>\n                      sequences of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      was established. Population genetic analyses were performed to evaluate haplotype and nucleotide diversity, analyze haplotypic distribution patterns of\n                      <jats:italic>Pfs25<\/jats:italic>\n                      in different geographical populations, and construct a haplotype network. Neutrality tests were conducted to determine evidence of natural selection. Homology models of the\n                      <jats:italic>Pfs25<\/jats:italic>\n                      haplotypes were constructed, subjected to molecular dynamics (MD), and analyzed in terms of flexibility and percentages of secondary structures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>Pfs25<\/jats:italic>\n                      gene of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      was found to have 11 unique haplotypes. Of these, haplotype 1 (H1) and H2, the major haplotypes, represented 70% and 22% of the population, respectively, and were dominant in Asia, whereas only H1 was dominant in Africa, Central America, and South America. Other haplotypes were rare and region-specific, resulting in unique distribution patterns in different geographical populations. The diversity in\n                      <jats:italic>Pfs25<\/jats:italic>\n                      originated from ten single-nucleotide polymorphism (SNP) loci located in the epidermal growth factor (EGF)-like domains and anchor domain. Of these, an SNP at position 392 (G\n                      <jats:underline>G<\/jats:underline>\n                      A\/G\n                      <jats:underline>C<\/jats:underline>\n                      A), resulting in amino acid substitution 131 (Gly\/Ala), defined the two major haplotypes. The MD results showed that the structures of H1 and H2 variants were relatively similar. Limited polymorphism in\n                      <jats:italic>Pfs25<\/jats:italic>\n                      could likely be due to negative selection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The study successfully established a\n                      <jats:italic>Pfs25<\/jats:italic>\n                      sequence database that can become an essential tool for monitoring vaccine efficacy, designing assays for detecting malaria carriers, and conducting epidemiological studies of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      . The discovery of the two major haplotypes, H1 and H2, and their conserved structures suggests that the current Pfs25-based vaccines could be used globally for malaria control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-021-05078-6","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T12:19:45Z","timestamp":1636373985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Global diversity of the gene encoding the Pfs25 protein\u2014a Plasmodium falciparum transmission-blocking vaccine candidate"],"prefix":"10.1186","volume":"14","author":[{"given":"Pornpawee","family":"Sookpongthai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korawich","family":"Utayopas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thassanai","family":"Sitthiyotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theerakamol","family":"Pengsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morakot","family":"Kaewthamasorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittikhun","family":"Wangkanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongchai","family":"Harnyuttanakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surasak","family":"Chunsrivirot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-1961","authenticated-orcid":false,"given":"Sittiporn","family":"Pattaradilokrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"5078_CR1","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1038\/s41467-020-19988-z","volume":"11","author":"SK Prajapati","year":"2020","unstructured":"Prajapati SK, Ayanful-Torgby R, Pava Z, Barbeau MC, Acquah FK, Cudjoe E, et al. The transcriptome of circulating sexually committed Plasmodium falciparum ring stage parasites forecasts malaria transmission potential. Nat Commun. 2020;11:6159.","journal-title":"Nat Commun"},{"key":"5078_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1186\/s12864-019-6322-9","volume":"20","author":"R van Biljon","year":"2019","unstructured":"van Biljon R, van Wyk R, Painter HJ, Orchard L, Reader J, Niemand J, et al. Hierarchical transcriptional control regulates Plasmodium falciparum sexual differentiation. BMC Genomics. 2019;20:920.","journal-title":"BMC Genomics"},{"key":"5078_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature24280","volume":"551","author":"A Poran","year":"2017","unstructured":"Poran A, Notzel C, Aly O, Mencia-Trinchant N, Harris CT, Guzman ML, et al. Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites. Nature. 2017;551:95\u20139.","journal-title":"Nature"},{"key":"5078_CR4","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.3389\/fimmu.2018.03126","volume":"9","author":"JA Chan","year":"2018","unstructured":"Chan JA, Drew DR, Reiling L, Lisboa-Pinto A, Dinko B, Sutherland CJ, et al. Low levels of human antibodies to gametocyte-infected erythrocytes contrasts the PfEMP1-dominant response to asexual stages in P. falciparum malaria. Front Immunol. 2018;9:3126.","journal-title":"Front Immunol"},{"key":"5078_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4269\/ajtmh.1992.46.711","volume":"46","author":"PM Graves","year":"1992","unstructured":"Graves PM, Doubrovsky A, Sattabongkot J, Battistutta D. Human antibody responses to epitopes on the Plasmodium falciparum gametocyte antigen PFS 48\/45 and their relationship to infectivity of gametocyte carriers. Am J Trop Med Hyg. 1992;46:711\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5078_CR6","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/s41467-021-21955-1","volume":"12","author":"CH Coelho","year":"2021","unstructured":"Coelho CH, Tang WK, Burkhardt M, Galson JD, Muratova O, Salinas ND, et al. A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes. Nat Commun. 2021;12:1750.","journal-title":"Nat Commun"},{"key":"5078_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41541-018-0065-5","volume":"3","author":"GE Canepa","year":"2018","unstructured":"Canepa GE, Molina-Cruz A, Yenkoidiok-Douti L, Calvo E, Williams AE, Burkhardt M, et al. Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission. NPJ Vaccines. 2018;3:26.","journal-title":"NPJ Vaccines"},{"key":"5078_CR8","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1038\/s41467-019-11980-6","volume":"10","author":"B McLeod","year":"2019","unstructured":"McLeod B, Miura K, Scally SW, Bosch A, Nguyen N, Shin H, et al. Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25. Nat Commun. 2019;10:4328.","journal-title":"Nat Commun"},{"key":"5078_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1128\/IAI.01438-13","volume":"82","author":"R Kumar","year":"2014","unstructured":"Kumar R, Angov E, Kumar N. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun. 2014;82:1453\u20139.","journal-title":"Infect Immun"},{"key":"5078_CR10","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1128\/IAI.00016-13","volume":"81","author":"DF Da","year":"2013","unstructured":"Da DF, Dixit S, Sattabonkot J, Mu J, Abate L, Ramineni B, et al. Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds. Infect Immun. 2013;81:1984\u20139.","journal-title":"Infect Immun"},{"key":"5078_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14760584.2021.1878028","volume":"20","author":"PE Duffy","year":"2021","unstructured":"Duffy PE. Transmission-blocking vaccines: harnessing herd immunity for malaria elimination. Expert Rev Vaccines. 2021;20:185\u201398.","journal-title":"Expert Rev Vaccines"},{"key":"5078_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/333074a0","volume":"333","author":"DC Kaslow","year":"1988","unstructured":"Kaslow DC, Quakyi IA, Syin C, Raum MG, Keister DB, Coligan JE, et al. A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature. 1988;333:74\u20136.","journal-title":"Nature"},{"key":"5078_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0166-6851(89)90134-5","volume":"32","author":"DC Kaslow","year":"1989","unstructured":"Kaslow DC, Quakyi IA, Keister DB. Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum. Mol Biochem Parasitol. 1989;32:101\u20133.","journal-title":"Mol Biochem Parasitol"},{"key":"5078_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nature01094","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner MJ, Shallom SJ, Carlton JM, Salzberg SL, Nene V, Shoaibi A, et al. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14. Nature. 2002;419:531\u20134.","journal-title":"Nature"},{"key":"5078_CR15","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1084\/jem.162.5.1460","volume":"162","author":"AN Vermeulen","year":"1985","unstructured":"Vermeulen AN, Ponnudurai T, Beckers PJ, Verhave JP, Smits MA, Meuwissen JH. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med. 1985;162:1460\u201376.","journal-title":"J Exp Med"},{"key":"5078_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0166-6851(86)90027-7","volume":"20","author":"AN Vermeulen","year":"1986","unstructured":"Vermeulen AN, van Deursen J, Brakenhoff RH, Lensen TH, Ponnudurai T, Meuwissen JH. Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol Biochem Parasitol. 1986;20:155\u201363.","journal-title":"Mol Biochem Parasitol"},{"key":"5078_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ab.2017.11.009","volume":"542","author":"SM Lee","year":"2018","unstructured":"Lee SM, Plieskatt J, King CR. Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate. Anal Biochem. 2018;542:20\u20133.","journal-title":"Anal Biochem"},{"key":"5078_CR18","first-page":"193","volume":"8","author":"B Sharma","year":"2008","unstructured":"Sharma B. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study. In Silico Biol. 2008;8:193\u2013206.","journal-title":"In Silico Biol"},{"key":"5078_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/BF03401770","volume":"4","author":"T Tsuboi","year":"1998","unstructured":"Tsuboi T, Kaslow DC, Gozar MM, Tachibana M, Cao YM, Torii M. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates. Mol Med. 1998;4:772\u201382.","journal-title":"Mol Med"},{"key":"5078_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4269\/ajtmh.2003.69.536","volume":"69","author":"J Sattabongkot","year":"2003","unstructured":"Sattabongkot J, Tsuboi T, Hisaeda H, Tachibana M, Suwanabun N, Rungruang T, et al. Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates. Am J Trop Med Hyg. 2003;69:536\u201341.","journal-title":"Am J Trop Med Hyg"},{"key":"5078_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0166-6851(00)00265-6","volume":"110","author":"RM del Carmen","year":"2000","unstructured":"del Carmen RM, Gerold P, Dessens J, Kurtenbach K, Schwartz RT, Sinden RE, et al. Characterisation and expression of Pbs25, a sexual and sporogonic stage specific protein of Plasmodium berghei. Mol Biochem Parasitol. 2000;110:147\u201359.","journal-title":"Mol Biochem Parasitol"},{"key":"5078_CR22","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1093\/emboj\/20.15.3975","volume":"20","author":"AM Tomas","year":"2001","unstructured":"Tomas AM, Margos G, Dimopoulos G, van Lin LH, de Koning-Ward TF, Sinha R, et al. P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions. EMBO J. 2001;20:3975\u201383.","journal-title":"EMBO J"},{"key":"5078_CR23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1128\/IAI.01409-07","volume":"76","author":"G Mlambo","year":"2008","unstructured":"Mlambo G, Maciel J, Kumar N. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect Immun. 2008;76:2018\u201324.","journal-title":"Infect Immun"},{"key":"5078_CR24","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41598-017-18831-8","volume":"8","author":"KA Sala","year":"2018","unstructured":"Sala KA, Angrisano F, Da DF, Taylor IJ, Churcher TS, Blagborough AM. Immunization with transgenic rodent malaria parasites expressing Pfs25 induces potent transmission-blocking activity. Sci Rep. 2018;8:1573.","journal-title":"Sci Rep"},{"key":"5078_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.174.5.1203","volume":"174","author":"PJ Barr","year":"1991","unstructured":"Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J Exp Med. 1991;174:1203\u20138.","journal-title":"J Exp Med"},{"key":"5078_CR26","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1128\/iai.62.12.5576-5580.1994","volume":"62","author":"DC Kaslow","year":"1994","unstructured":"Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect Immun. 1994;62:5576\u201380.","journal-title":"Infect Immun"},{"key":"5078_CR27","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1128\/IAI.02980-14","volume":"83","author":"KP Patra","year":"2015","unstructured":"Patra KP, Li F, Carter D, Gregory JA, Baga S, Reed SG, et al. Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun. 2015;83:1799\u2013808.","journal-title":"Infect Immun"},{"key":"5078_CR28","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1016\/j.vaccine.2018.08.033","volume":"36","author":"JA Chichester","year":"2018","unstructured":"Chichester JA, Green BJ, Jones RM, Shoji Y, Miura K, Long CA, et al. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: a phase 1 dose-escalation study in healthy adults. Vaccine. 2018;36:5865\u201371.","journal-title":"Vaccine"},{"key":"5078_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S1473-3099(18)30344-X","volume":"18","author":"I Sagara","year":"2018","unstructured":"Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, et al. Safety and immunogenicity of Pfs25H-EPA\/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults. Lancet Infect Dis. 2018;18:969\u201382.","journal-title":"Lancet Infect Dis"},{"key":"5078_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nbt0594-494","volume":"12","author":"DC Kaslow","year":"1994","unstructured":"Kaslow DC, Shiloach J. Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. Biotechnology (N Y). 1994;12:494\u20139.","journal-title":"Biotechnology (N Y)"},{"key":"5078_CR31","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/S0264-410X(02)00701-6","volume":"21","author":"L Zou","year":"2003","unstructured":"Zou L, Miles AP, Wang J, Stowers AW. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine. 2003;21:1650\u20137.","journal-title":"Vaccine"},{"key":"5078_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1021\/acs.biochem.7b01099","volume":"57","author":"N Kapoor","year":"2018","unstructured":"Kapoor N, Vanjak I, Rozzelle J, Berges A, Chan W, Yin G, et al. Malaria derived glycosylphosphatidylinositol anchor enhances anti-Pfs25 functional antibodies that block malaria transmission. Biochemistry. 2018;57:516\u20139.","journal-title":"Biochemistry"},{"key":"5078_CR33","doi-asserted-by":"publisher","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","volume":"3","author":"Y Wu","year":"2008","unstructured":"Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS ONE. 2008;3:e2636.","journal-title":"PLoS ONE"},{"key":"5078_CR34","doi-asserted-by":"publisher","first-page":"e0163144","DOI":"10.1371\/journal.pone.0163144","volume":"11","author":"KR Talaat","year":"2016","unstructured":"Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, et al. Safety and immunogenicity of Pfs25-EPA\/Alhydrogel(R), a transmission blocking vaccine against Plasmodium falciparum: an open label study in malaria naive adults. PLoS ONE. 2016;11:e0163144.","journal-title":"PLoS ONE"},{"key":"5078_CR35","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.3389\/fimmu.2018.02780","volume":"9","author":"F Brod","year":"2018","unstructured":"Brod F, Miura K, Taylor I, Li Y, Marini A, Salman AM, et al. Combination of RTS, S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice. Front Immunol. 2018;9:2780.","journal-title":"Front Immunol"},{"key":"5078_CR36","doi-asserted-by":"publisher","first-page":"2ra5","DOI":"10.1126\/scitranslmed.3000257","volume":"1","author":"SL Takala","year":"2009","unstructured":"Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, et al. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med. 2009;1:2ra5.","journal-title":"Sci Transl Med."},{"key":"5078_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/339342","volume":"185","author":"B Genton","year":"2002","unstructured":"Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, et al. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua New Guinea. J Infect Dis. 2002;185:820\u20137.","journal-title":"J Infect Dis"},{"key":"5078_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13071-018-2630-1","volume":"11","author":"S Pattaradilokrat","year":"2018","unstructured":"Pattaradilokrat S, Trakoolsoontorn C, Simpalipan P, Warrit N, Kaewthamasorn M, Harnyuttanakorn P. Size and sequence polymorphisms in the glutamate-rich protein gene of the human malaria parasite Plasmodium falciparum in Thailand. Parasit Vectors. 2018;11:49.","journal-title":"Parasit Vectors"},{"key":"5078_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3347\/kjp.2018.56.2.153","volume":"56","author":"L Lumkul","year":"2018","unstructured":"Lumkul L, Sawaswong V, Simpalipan P, Kaewthamasorn M, Harnyuttanakorn P, Pattaradilokrat S. Unraveling haplotype diversity of the apical membrane antigen-1 gene in Plasmodium falciparum populations in Thailand. Korean J Parasitol. 2018;56:153\u201365.","journal-title":"Korean J Parasitol"},{"key":"5078_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12936-016-1566-1","volume":"15","author":"S Pattaradilokrat","year":"2016","unstructured":"Pattaradilokrat S, Sawaswong V, Simpalipan P, Kaewthamasorn M, Siripoon N, Harnyuttanakorn P. Genetic diversity of the merozoite surface protein-3 gene in Plasmodium falciparum populations in Thailand. Malar J. 2016;15:517.","journal-title":"Malar J"},{"key":"5078_CR41","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1128\/MCB.19.2.967","volume":"19","author":"KJ Dechering","year":"1999","unstructured":"Dechering KJ, Kaan AM, Mbacham W, Wirth DF, Eling W, Konings RN, et al. Isolation and functional characterization of two distinct sexual-stage-specific promoters of the human malaria parasite Plasmodium falciparum. Mol Cell Biol. 1999;19:967\u201378.","journal-title":"Mol Cell Biol"},{"key":"5078_CR42","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/tmi.12990","volume":"22","author":"H Kaur","year":"2017","unstructured":"Kaur H, Sehgal R, Goyal K, Makkar N, Yadav R, Bharti PK, et al. Genetic diversity of Plasmodium falciparum merozoite surface protein-1 (block 2), glutamate-rich protein and sexual stage antigen Pfs25 from Chandigarh, North India. Trop Med Int Health. 2017;22:1590\u20138.","journal-title":"Trop Med Int Health"},{"key":"5078_CR43","doi-asserted-by":"publisher","first-page":"e0182674","DOI":"10.1371\/journal.pone.0182674","volume":"12","author":"P Patel","year":"2017","unstructured":"Patel P, Bharti PK, Bansal D, Raman RK, Mohapatra PK, Sehgal R, et al. Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: implication for vaccine development. PLoS ONE. 2017;12:e0182674.","journal-title":"PLoS ONE"},{"key":"5078_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1475-2875-13-54","volume":"13","author":"P Simpalipan","year":"2014","unstructured":"Simpalipan P, Pattaradilokrat S, Siripoon N, Seugorn A, Kaewthamasorn M, Butcher RD, et al. Diversity and population structure of Plasmodium falciparum in Thailand based on the spatial and temporal haplotype patterns of the C-terminal 19-kDa domain of merozoite surface protein-1. Malar J. 2014;13:54.","journal-title":"Malar J"},{"key":"5078_CR45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature01097","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419:498\u2013511.","journal-title":"Nature"},{"issue":"Database issue","key":"5078_CR46","doi-asserted-by":"publisher","first-page":"D539","DOI":"10.1093\/nar\/gkn814","volume":"37","author":"C Aurrecoechea","year":"2009","unstructured":"Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009;37(Database issue):D539\u201343.","journal-title":"Nucleic Acids Res"},{"key":"5078_CR47","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"S Kumar","year":"2016","unstructured":"Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870\u20134.","journal-title":"Mol Biol Evol"},{"key":"5078_CR48","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/molbev\/msx248","volume":"34","author":"J Rozas","year":"2017","unstructured":"Rozas J, Ferrer-Mata A, Sanchez-DelBarrio JC, Guirao-Rico S, Librado P, Ramos-Onsins SE, et al. DnaSP 6: DNA sequence polymorphism analysis of large data sets. Mol Biol Evol. 2017;34:3299\u2013302.","journal-title":"Mol Biol Evol"},{"key":"5078_CR49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/2041-210X.12410","volume":"6","author":"JW Leigh","year":"2015","unstructured":"Leigh JW, Bryant D. POPART: full-feature software for haplotype network construction. Methods Ecol Evol. 2015;6:1110\u20136.","journal-title":"Methods Ecol Evol"},{"key":"5078_CR50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/genetics\/123.3.585","volume":"123","author":"F Tajima","year":"1989","unstructured":"Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123:585\u201395.","journal-title":"Genetics"},{"key":"5078_CR51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/genetics\/133.3.693","volume":"133","author":"YX Fu","year":"1993","unstructured":"Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133:693\u2013709.","journal-title":"Genetics"},{"key":"5078_CR52","doi-asserted-by":"publisher","first-page":"e1000304","DOI":"10.1371\/journal.pgen.1000304","volume":"4","author":"S Kryazhimskiy","year":"2008","unstructured":"Kryazhimskiy S, Plotkin JB. The population genetics of dN\/dS. PLoS Genet. 2008;4:e1000304.","journal-title":"PLoS Genet"},{"key":"5078_CR53","first-page":"47","volume":"1","author":"L Excoffier","year":"2007","unstructured":"Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online. 2007;1:47\u201350.","journal-title":"Evol Bioinform Online."},{"key":"5078_CR54","doi-asserted-by":"publisher","first-page":"vey016","DOI":"10.1093\/ve\/vey016","volume":"4","author":"MA Suchard","year":"2018","unstructured":"Suchard MA, Lemey P, Baele G, Ayres DL, Drummond AJ, Rambaut A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4:vey016.","journal-title":"Virus Evol."},{"key":"5078_CR55","doi-asserted-by":"crossref","unstructured":"Wilgenbusch JC, Swofford D. Inferring evolutionary trees with PAUP*. Curr Protoc Bioinformatics. 2003;Chapter 6:Unit 6.4.","DOI":"10.1002\/0471250953.bi0604s00"},{"key":"5078_CR56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF02101694","volume":"22","author":"M Hasegawa","year":"1985","unstructured":"Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol. 1985;22:160\u201374.","journal-title":"J Mol Evol"},{"key":"5078_CR57","doi-asserted-by":"publisher","first-page":"11078","DOI":"10.1038\/ncomms11078","volume":"7","author":"SA Sundararaman","year":"2016","unstructured":"Sundararaman SA, Plenderleith LJ, Liu W, Loy DE, Learn GH, Li Y, et al. Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria. Nat Commun. 2016;7:11078.","journal-title":"Nat Commun"},{"key":"5078_CR58","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1038\/s41598-017-09654-8","volume":"7","author":"M Bertoni","year":"2017","unstructured":"Bertoni M, Kiefer F, Biasini M, Bordoli L, Schwede T. Modeling protein quaternary structure of homo-and hetero-oligomers beyond binary interactions by homology. Sci Rep. 2017;7:10480.","journal-title":"Sci Rep"},{"issue":"D1","key":"5078_CR59","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","volume":"45","author":"S Bienert","year":"2017","unstructured":"Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, et al. The SWISS-MODEL Repository\u2014new features and functionality. Nucleic Acids Res. 2017;45(D1):D313\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"5078_CR60","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis. 2009;30(Suppl 1):S162\u201373.","journal-title":"Electrophoresis"},{"key":"5078_CR61","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","volume":"36","author":"G Studer","year":"2020","unstructured":"Studer G, Rempfer C, Waterhouse AM, Gumienny R, Haas J, Schwede T. QMEANDisCo\u2014distance constraints applied on model quality estimation. Bioinformatics. 2020;36:1765\u201371.","journal-title":"Bioinformatics"},{"issue":"W1","key":"5078_CR62","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.","journal-title":"Nucleic Acids Res"},{"key":"5078_CR63","volume-title":"AMBER 2018","author":"D Case","year":"2018","unstructured":"Case D, Ben-Shalom I, Brozell S, Cerutti D, Cheatham T III, Cruzeiro V, et al. AMBER 2018. San Francisco: University of California; 2018."},{"issue":"Web Server issu","key":"5078_CR64","doi-asserted-by":"publisher","first-page":"W368","DOI":"10.1093\/nar\/gki464","volume":"33","author":"JC Gordon","year":"2005","unstructured":"Gordon JC, Myers JB, Folta T, Shoja V, Heath LS, Onufriev A. H++: a server for estimating p K as and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33(Web Server issue):W368\u201371.","journal-title":"Nucleic Acids Res"},{"key":"5078_CR65","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696\u2013713.","journal-title":"J Chem Theory Comput"},{"key":"5078_CR66","doi-asserted-by":"publisher","first-page":"28001","DOI":"10.1021\/acsomega.0c03521","volume":"5","author":"T Charoenwongpaiboon","year":"2020","unstructured":"Charoenwongpaiboon T, Punnatin P, Klaewkla M, Pramoj Na Ayutthaya P, Wangpaiboon K, Chunsrivirot S, et al. Conserved Calcium-binding residues at the Ca-I site involved in fructooligosaccharide synthesis by Lactobacillus reuteri 121 inulosucrase. ACS Omega. 2020;5:28001\u201311.","journal-title":"ACS Omega"},{"key":"5078_CR67","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ijbiomac.2019.08.151","volume":"140","author":"P Kanjanatanin","year":"2019","unstructured":"Kanjanatanin P, Pichyangkura R, Sitthiyotha T, Charoenwongpaiboon T, Wangpaiboon K, Chunsrivirot S. Computational design of Bacillus licheniformis RN-01 levansucrase for control of the chain length of levan-type fructooligosaccharides. Int J Biol Macromol. 2019;140:1239\u201348.","journal-title":"Int J Biol Macromol"},{"key":"5078_CR68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijbiomac.2020.05.102","volume":"160","author":"M Klaewkla","year":"2020","unstructured":"Klaewkla M, Pichyangkura R, Charoenwongpaiboon T, Wangpaiboon K, Chunsrivirot S. Computational design of oligosaccharide producing levansucrase from Bacillus licheniformis RN-01 to improve its thermostability for production of levan-type fructooligosaccharides from sucrose. Int J Biol Macromol. 2020;160:252\u201363.","journal-title":"Int J Biol Macromol"},{"key":"5078_CR69","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00894-012-1565-2","volume":"19","author":"W Mokmak","year":"2013","unstructured":"Mokmak W, Chunsrivirot S, Assawamakin A, Choowongkomon K, Tongsima S. Molecular dynamics simulations reveal structural instability of human trypsin inhibitor upon D50E and Y54H mutations. J Mol Model. 2013;19:521\u20138.","journal-title":"J Mol Model"},{"key":"5078_CR70","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/cbdd.12334","volume":"84","author":"W Mokmak","year":"2014","unstructured":"Mokmak W, Chunsrivirot S, Hannongbua S, Yuthavong Y, Tongsima S, Kamchonwongpaisan S. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum. Chem Biol Drug Des. 2014;84:450\u201361.","journal-title":"Chem Biol Drug Des"},{"key":"5078_CR71","doi-asserted-by":"publisher","first-page":"e0198484","DOI":"10.1371\/journal.pone.0198484","volume":"13","author":"P Pramoj Na Ayutthaya","year":"2018","unstructured":"Pramoj Na Ayutthaya P, Chanchao C, Chunsrivirot S. Insight into the substrate specificity change caused by the Y227H mutation of \u03b1-glucosidase III from the European honeybee (Apis mellifera) through molecular dynamics simulations. PLoS ONE. 2018;13:e0198484.","journal-title":"PLoS ONE"},{"issue":"3","key":"5078_CR72","doi-asserted-by":"publisher","first-page":"e0229734","DOI":"10.1371\/journal.pone.0229734","volume":"15","author":"P Punnatin","year":"2020","unstructured":"Punnatin P, Chanchao C, Chunsrivirot S. Molecular dynamics reveals insight into how N226P and H227Y mutations affect maltose binding in the active site of \u03b1-glucosidase II from European honeybee, Apis mellifera. PLoS ONE. 2020;15(3):e0229734.","journal-title":"PLoS ONE"},{"key":"5078_CR73","doi-asserted-by":"publisher","first-page":"10930","DOI":"10.1021\/acs.jpcb.0c07890","volume":"124","author":"T Sitthiyotha","year":"2020","unstructured":"Sitthiyotha T, Chunsrivirot S. Computational design of 25-mer peptide binders of SARS-CoV-2. J Phys Chem B. 2020;124:10930\u201342.","journal-title":"J Phys Chem B"},{"key":"5078_CR74","doi-asserted-by":"publisher","first-page":"e0204915","DOI":"10.1371\/journal.pone.0204915","volume":"13","author":"T Sitthiyotha","year":"2018","unstructured":"Sitthiyotha T, Pichyangkura R, Chunsrivirot S. Molecular dynamics provides insight into how N251A and N251Y mutations in the active site of Bacillus licheniformis RN-01 levansucrase disrupt production of long-chain levan. PLoS ONE. 2018;13:e0204915.","journal-title":"PLoS ONE"},{"key":"5078_CR75","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, G\u00f6tz AW, Poole D, Le Grand S, Walker RC. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald. J Chem Theory Comput. 2013;9:3878\u201388.","journal-title":"J Chem Theory Comput"},{"key":"5078_CR76","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/ct200909j","volume":"8","author":"AW G\u00f6tz","year":"2012","unstructured":"G\u00f6tz AW, Williamson MJ, Xu D, Poole D, Le Grand S, Walker RC. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. J Chem Theory Comput. 2012;8:1542\u201355.","journal-title":"J Chem Theory Comput"},{"key":"5078_CR77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cpc.2012.09.022","volume":"184","author":"S Le Grand","year":"2013","unstructured":"Le Grand S, G\u00f6tz AW, Walker RC. SPFP: Speed without compromise\u2014a mixed precision model for GPU accelerated molecular dynamics simulations. Comput Phys Commun. 2013;184:374\u201380.","journal-title":"Comput Phys Commun"},{"key":"5078_CR78","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1063\/1.465608","volume":"99","author":"DM York","year":"1993","unstructured":"York DM, Darden TA, Pedersen LG. The effect of long-range electrostatic interactions in simulations of macromolecular crystals: A comparison of the Ewald and truncated list methods. J Chem Phys. 1993;99:8345.","journal-title":"J Chem Phys"},{"key":"5078_CR79","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cplett.2003.10.013","volume":"381","author":"X Wu","year":"2003","unstructured":"Wu X, Brooks BR. Self-guided Langevin dynamics simulation method. Chem Phys Lett. 2003;381:512\u20138.","journal-title":"Chem Phys Lett"},{"key":"5078_CR80","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE III. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9:3084\u201395.","journal-title":"J Chem Theory Comput"},{"key":"5078_CR81","doi-asserted-by":"publisher","first-page":"W389","DOI":"10.1093\/nar\/gkv332","volume":"43","author":"A Drozdetskiy","year":"2015","unstructured":"Drozdetskiy A, Cole C, Procter J, Barton GJ. JPred4: a protein secondary structure prediction server. Nucleic Acids Res. 2015;43:W389\u201394.","journal-title":"Nucleic Acids Res"},{"key":"5078_CR82","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1107\/S0907444994001782","volume":"50","author":"EA Stura","year":"1994","unstructured":"Stura EA, Satterthwait AC, Calvo JC, Stefanko RS, Langeveld JP, Kaslow DC. Crystallization of an intact monoclonal antibody (4B7) against Plasmodium falciparum malaria with peptides from the Pfs25 protein antigen. Acta Crystallogr D Biol Crystallogr. 1994;50:556\u201362.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"5078_CR83","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1107\/S0907444994001356","volume":"50","author":"EA Stura","year":"1994","unstructured":"Stura EA, Kang AS, Stefanko RS, Calvo JC, Kaslow DC, Satterthwait AC. Crystallization, sequence and preliminary crystallographic data for transmission-blocking anti-malaria Fab 4B7 with cyclic peptides from the Pfs25 protein of P. falciparum. Acta Crystallogr D Biol Crystallogr. 1994;50:535\u201342.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"5078_CR84","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41467-017-01924-3","volume":"8","author":"SW Scally","year":"2017","unstructured":"Scally SW, McLeod B, Bosch A, Miura K, Liang Q, Carroll S, et al. Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25. Nat Commun. 2017;8:1568.","journal-title":"Nat Commun"},{"key":"5078_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0166-6851(01)00386-3","volume":"119","author":"AA Escalante","year":"2002","unstructured":"Escalante AA, Grebert HM, Chaiyaroj SC, Riggione F, Biswas S, Nahlen BL, et al. Polymorphism in the gene encoding the Pfs48\/45 antigen of Plasmodium falciparum. XI. Asembo bay cohort project. Mol Biochem Parasitol. 2002;119:17\u201322.","journal-title":"Mol Biochem Parasitol"},{"key":"5078_CR86","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/oxfordjournals.molbev.a026247","volume":"17","author":"TJ Anderson","year":"2000","unstructured":"Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol. 2000;17:1467\u201382.","journal-title":"Mol Biol Evol"},{"key":"5078_CR87","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11174","volume":"487","author":"M Manske","year":"2012","unstructured":"Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature. 2012;487:375\u20139.","journal-title":"Nature"},{"key":"5078_CR88","doi-asserted-by":"publisher","first-page":"e5568","DOI":"10.1371\/journal.pone.0005568","volume":"4","author":"KK Tetteh","year":"2009","unstructured":"Tetteh KK, Stewart LB, Ochola LI, Amambua-Ngwa A, Thomas AW, Marsh K, et al. Prospective identification of malaria parasite genes under balancing selection. PLoS ONE. 2009;4:e5568.","journal-title":"PLoS ONE"},{"key":"5078_CR89","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12688\/wellcomeopenres.16168.1","volume":"6","author":"G Malaria","year":"2021","unstructured":"Malaria G, Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, et al. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Res. 2021;6:42.","journal-title":"Wellcome Open Res."},{"key":"5078_CR90","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0169-4758(96)10077-6","volume":"13","author":"DJ Conway","year":"1997","unstructured":"Conway DJ. Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasitol Today. 1997;13:26\u20139.","journal-title":"Parasitol Today"},{"key":"5078_CR91","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1073\/pnas.1917042117","volume":"117","author":"A Molina-Cruz","year":"2020","unstructured":"Molina-Cruz A, Canepa GE, Alves ESTL, Williams AE, Nagyal S, Yenkoidiok-Douti L, et al. Plasmodium falciparum evades immunity of anopheline mosquitoes by interacting with a Pfs47 midgut receptor. Proc Natl Acad Sci U S A. 2020;117:2597\u2013605.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5078_CR92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.meegid.2013.01.006","volume":"16","author":"JE Crawford","year":"2013","unstructured":"Crawford JE, Rottschaefer SM, Coulibaly B, Sacko M, Niare O, Riehle MM, et al. No evidence for positive selection at two potential targets for malaria transmission-blocking vaccines in Anopheles gambiae s.s. Infect Genet Evol. 2013;16:87\u201392.","journal-title":"Infect Genet Evol"},{"key":"5078_CR93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1756-3305-5-69","volume":"5","author":"ME Sinka","year":"2012","unstructured":"Sinka ME, Bangs MJ, Manguin S, Rubio-Palis Y, Chareonviriyaphap T, Coetzee M, et al. A global map of dominant malaria vectors. Parasit Vectors. 2012;5:69.","journal-title":"Parasit Vectors"},{"key":"5078_CR94","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2875-5-55","volume":"5","author":"JS Richards","year":"2006","unstructured":"Richards JS, MacDonald NJ, Eisen DP. Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates. Malar J. 2006;5:55.","journal-title":"Malar J"},{"key":"5078_CR95","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.1520426112","volume":"112","author":"A Molina-Cruz","year":"2015","unstructured":"Molina-Cruz A, Canepa GE, Kamath N, Pavlovic NV, Mu J, Ramphul UN, et al. Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory. Proc Natl Acad Sci U S A. 2015;112:15178\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5078_CR96","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1128\/EC.00060-07","volume":"6","author":"AK Saxena","year":"2007","unstructured":"Saxena AK, Wu Y, Garboczi DN. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines. Eukaryot Cell. 2007;6:1260\u20135.","journal-title":"Eukaryot Cell"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-05078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-021-05078-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-05078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T06:07:18Z","timestamp":1699769238000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-021-05078-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5078"],"URL":"https:\/\/doi.org\/10.1186\/s13071-021-05078-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-779485\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Biosafety Committee of Chulalongkorn University (SC CU-IBC-004\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}